<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JAAD Int</journal-id><journal-id journal-id-type="iso-abbrev">JAAD Int</journal-id><journal-id journal-id-type="pmc-domain-id">4085</journal-id><journal-id journal-id-type="pmc-domain">jdin</journal-id><journal-title-group><journal-title>JAAD International</journal-title></journal-title-group><issn pub-type="epub">2666-3287</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10808986</article-id><article-id pub-id-type="pmcid-ver">PMC10808986.1</article-id><article-id pub-id-type="pmcaid">10808986</article-id><article-id pub-id-type="pmcaiid">10808986</article-id><article-id pub-id-type="pmid">38274396</article-id><article-id pub-id-type="doi">10.1016/j.jdin.2023.11.005</article-id><article-id pub-id-type="pii">S2666-3287(23)00175-X</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Association between lifetime smoking and cutaneous squamous cell carcinoma: A 2-sample Mendelian randomization study</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name name-style="western"><surname>Lee</surname><given-names initials="T">Truelian</given-names></name><degrees>BA</degrees><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au2"><name name-style="western"><surname>George</surname><given-names initials="CD">Christopher D.</given-names></name><degrees>MD</degrees><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au3"><name name-style="western"><surname>Jiang</surname><given-names initials="C">Chen</given-names></name><degrees>PhD</degrees><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au4"><name name-style="western"><surname>Asgari</surname><given-names initials="MM">Maryam M.</given-names></name><degrees>MD, MPH</degrees><xref rid="aff4" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="au5"><name name-style="western"><surname>Nijsten</surname><given-names initials="T">Tamar</given-names></name><degrees>MD, PhD</degrees><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au6"><name name-style="western"><surname>Pardo</surname><given-names initials="LM">Luba M.</given-names></name><degrees>MD, PhD</degrees><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au7"><name name-style="western"><surname>Choquet</surname><given-names initials="H">H&#233;l&#232;ne</given-names></name><degrees>PhD</degrees><email>Helene.Choquet@kp.org</email><xref rid="aff3" ref-type="aff">c</xref><xref rid="cor1" ref-type="corresp">&#8727;</xref></contrib><aff id="aff1"><label>a</label>Harvard Medical School, Boston, Massachusetts</aff><aff id="aff2"><label>b</label>Department of Dermatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands</aff><aff id="aff3"><label>c</label>Division of Research, Kaiser Permanente Northern California, Oakland, California</aff><aff id="aff4"><label>d</label>Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado</aff></contrib-group><author-notes><corresp id="cor1"><label>&#8727;</label>Correspondence to: H&#233;l&#232;ne Choquet, PhD, Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612. <email>Helene.Choquet@kp.org</email></corresp></author-notes><pub-date pub-type="collection"><month>3</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>03</day><month>12</month><year>2023</year></pub-date><volume>14</volume><issue-id pub-id-type="pmc-issue-id">449683</issue-id><fpage>69</fpage><lpage>76</lpage><history><date date-type="accepted"><day>22</day><month>11</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>12</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>25</day><month>01</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-22 01:25:14.833"><day>22</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>American Academy of Dermatology, Inc.</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="abs0010"><sec><title>Background/Purpose</title><p>Cutaneous squamous cell carcinoma (cSCC) is one of the most common malignancies worldwide. While several environmental risk factors for cSCC are well established, there is conflicting evidence on cigarette smoking (and its potential causal effect) and cSCC risk. Furthermore, it is unclear if these potential associations represent causal, modifiable risk factors for cSCC development. This study aims to assess the nature of the associations between cigarette smoking traits (smoking initiation, amount smoked, and lifetime smoking exposure) and cSCC risk using two-sample Mendelian randomization analyses.</p></sec><sec><title>Methods</title><p>Genetic instruments, based on common genetic variants associated with cigarette smoking traits (<italic toggle="yes">P</italic>&#160;&lt;&#160;5&#160;&#215;&#160;10<sup>&#8722;8</sup>), were derived from published genome-wide association studies (GWASs). For cSCC, we used GWAS summary statistics from the Kaiser Permanente GERA cohort (7701 cSCC cases and 60,167 controls; all non-Hispanic Whites).</p></sec><sec><title>Results</title><p>We found modest evidence that genetically determined lifetime smoking was associated with cSCC (inverse-variance weighted method: OR[95% CI]&#160;=&#160;1.47[1.09-1.98]; <italic toggle="yes">P</italic>&#160;=&#160;.012), suggesting it may be a causal risk factor for cSCC. We did not detect any evidence of association between genetically determined smoking initiation or amount smoked and cSCC risk.</p></sec><sec><title>Conclusion</title><p>Study findings highlight the importance of smoking prevention and may support risk-stratified cSCC screening strategies based on carcinogen exposure and other genetic and clinical information.</p></sec></abstract><kwd-group id="kwrds0010"><title>Key words</title><kwd>cigarette smoking</kwd><kwd>cutaneous squamous cell carcinoma</kwd><kwd>genetic epidemiology</kwd><kwd>Mendelian randomization</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta><def-list><title>Abbreviations used</title><def-item><term id="kwrd1030">cSCC</term><def><p>cutaneous squamous cell carcinoma</p></def></def-item><def-item><term id="kwrd4030">GERA</term><def><p>Genetic Epidemiology Research on Adult Health and Aging</p></def></def-item><def-item><term id="kwrd6030">GSCAN</term><def><p>GWAS and Sequencing Consortium of Alcohol and Nicotine use</p></def></def-item><def-item><term id="kwrd8030">GWAS</term><def><p>genome-wide association study</p></def></def-item><def-item><term id="kwrd9130">MR</term><def><p>Mendelian randomization</p></def></def-item><def-item><term id="kwrd9330">SNP</term><def><p>single nucleotide polymorphism</p></def></def-item><def-item><term id="kwrd9530">UKB</term><def><p>UK Biobank</p></def></def-item></def-list></front><body><p id="p0010">
<boxed-text id="dtbox1" position="float" orientation="portrait"><caption><title>Capsule Summary</title></caption><p id="p0015">
<list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#8226;</label><p id="p0020">Considering conflicting evidence regarding the association between cigarette smoking and cSCC, we investigated if there was genetic evidence of a potential causal relationship between cigarette smoking traits and cSCC risk.</p></list-item><list-item id="u0015"><label>&#8226;</label><p id="p0025">Our findings provide genetic evidence that increased lifetime smoking may be a causal risk factor for cSCC.</p></list-item></list>
</p></boxed-text>
</p><sec id="sec1"><title>Introduction</title><p id="p0030">Cutaneous squamous cell carcinoma (cSCC) is one of the most common skin cancers worldwide, with an increasing prevalence in recent years.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> cSCCs frequently occur in sun-exposed areas such as the head and neck.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> According to the Global Burden of Disease (GBD) study, the cutaneous malignancy with the largest worldwide increase in prevalence between 1990 and 2017 was cSCC with a 310% increase.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> In a more recent GBD analysis, there was an increase in the global all-age disability-adjusted life years for cSCC in both sexes combined, compared to that in 1990 and 2010.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref></p><p id="p0035">Besides well-established risk factors for cSCC, including genetic risk factors, such as those affecting pigmentation traits, and environmental factors (e.g., UV radiation exposure and immunosuppression),<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> cigarette smoking is a potential risk factor for cSCC, as it has been associated with a wide variety of neoplasms.<xref rid="bib5" ref-type="bibr">5</xref>, <xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref> Despite prior observational studies demonstrating a link&#160;between smoking and cSCC, the causal association between the 2 remains unclear.<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>&#160;Additional limitations to prior analyses include selection bias (nonparticipation could be related to smoking&#160;amount/status or people who smoke may have higher cumulative UV exposure levels) and difficulty in accurately assessing the amount and duration of smoking (certain studies did not distinguish between cigar and cigarettes, or former, never, and current smokers).<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref></p><p id="p0040">Compared to observational studies, Mendelian randomization (MR) studies help to assess the causal relation between an exposure and an outcome. In MR, genetic variants are used as instrumental variables (IVs), with the assumption that humans are all randomly assigned genetic variants from their parents.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> This is significant because genetic variants, if associated with the exposure and not directly with the outcome and not associated with confounders, can serve as a reliable IV, hence enabling causal inference. Because of the randomization in genetic variants in a population, MR can reduce the effect of confounding, reverse causation, and various biases seen in observational studies.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> Although the application of MR rests upon more extensive assumptions than a randomized controlled trial (RCT), MR can be used in cases where randomized controlled trials (RCTs) are not feasible or ethical.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="bib14" ref-type="bibr"><sup>14</sup></xref></p><p id="p0045">The present study aims to elucidate the causal association of cigarette smoking traits (ie, smoking initiation, amount smoked, and lifetime smoking exposure) with cSCC risk, and circumvent prior limitations, by using a two-sample MR approach. We used 3 separate cigarette smoking traits as the exposures, as those represent different stages of cigarette use: initiation for &#8220;smoking initiation,&#8221; heaviness for &#8220;amount smoked,&#8221; and initiation, duration, heaviness, and cessation for &#8220;lifetime smoking.&#8221; We compare genetic effect estimates for those 3 cigarette smoking traits (exposures) and cSCC risk (outcome) obtained through GWAS summary statistics, especially, from our previous GWAS of cSCC conducted in the Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> Through our study, we aim to highlight the potential value of integrating the desire to smoke (determined genetically) in cSCC risk assessment, thereby informing targeted prevention and screening strategies for populations at higher risk of developing the disease.</p></sec><sec id="sec2"><title>Methods</title><sec id="sec2.1"><title>Study design</title><p id="p0050">Two-sample MR analyses were conducted to investigate separately the association of genetically determined smoking initiation, genetically determined amount smoked, and genetically determined lifetime smoking exposure with the risk of cSCC. For each of the 3 exposures, we used the lead single-nucleotide polymorphisms (SNPs) previously reported as genome-wide significant (<italic toggle="yes">P</italic>&#160;&lt;&#160;5.0&#160;&#215;&#160;10<sup>-8</sup>) as a set of genetic instruments. Genetic instruments were then clumped using a window of 10&#160;Mb and maximal linkage disequilibrium of <italic toggle="yes">r</italic><sup>2</sup>&#160;=&#160;0.001 between instruments to ensure that genetic variants were independent. The different data sets used for this MR study are summarized in Supplementary Table I, available via Mendeley at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.17632/cnkvc82bgr.1" id="PC_linkqPulCKMf6M">https://doi.org/10.17632/cnkvc82bgr.1</ext-link>.</p></sec><sec id="sec2.2"><title>GWAS summary statistics for cSCC</title><p id="p0055">Genetic association data for cSCC risk (outcome) were retrieved from our previous GWAS study conducted in the GERA cohort.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> The GERA cohort consists of 110,266 adult members of the Kaiser Permanente Medical Care Plan, Northern California Region (KPNC), an integrated healthcare delivery system, that includes ongoing longitudinal electronic health records (EHRs).<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> The Institutional Review Board (IRB) of the Kaiser Foundation Research Institute approved all study procedures. Written informed consent was obtained from all participants. In the current study, we retrieved genetic association data from the GWAS of cSCC conducted in 7701 SCC cases and 60,167 controls; all GERA participants of European ancestry.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref></p></sec><sec id="sec2.3"><title>Genetic instruments for cigarette smoking traits</title><p id="p0060">Genetic variants as IVs for cigarette smoking initiation (ever having smoked regularly versus never) and amount smoked (number of cigarettes per day) were extracted from the most recent GWAS and Sequencing Consortium of Alcohol and Nicotine use (GSCAN) study.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> GWAS summary statistics for smoking initiation and amount smoked analyses,<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> included 805,431 and 326,497 individuals of European ancestry, respectively, from 42 cohorts (Supplementary Table II, available via Mendeley at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.17632/cnkvc82bgr.1" id="PC_linkEzs8ydwGta">https://doi.org/10.17632/cnkvc82bgr.1</ext-link>). Those GWAS summary statistics were publicly accessible at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://conservancy.umn.edu/handle/11299/241912" id="intref0010">https://conservancy.umn.edu/handle/11299/241912</ext-link>. After clumping, a total of 236 genetic instruments for smoking initiation and 45 for cigarettes per day were used for the MR analyses (Supplementary Tables III-IV, available via Mendeley at xxx). Thus, by using these genetic variants, we adhered to the key assumption that the IVs are robustly associated with the exposure, as those genetic variants were previously reported as genome-wide significant in the large GSCAN study,<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> making those strong IVs for cigarette smoking initiation and cigarettes per day. Moreover, the genetic scores of the 2 smoking-related traits have been previously reported to be associated with self-reported smoking behaviors in the GERA cohort.<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref></p><p id="p0065">We also used genetic variants as instrumental variables for lifetime smoking (represented by an index which captures smoking status, duration, heaviness, and cessation) from a GWAS conducted in 462,690 UK Biobank (UKB) participants of European ancestry (54% female; mean age (SD)&#160;=&#160;56.7 (8.0) years; 54% had never smoked).<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> The UKB is a longitudinal study following the health of approximately 500,000 participants aged 40-69&#160;years, recruited from across the United Kingdom between 2006 and 2010.<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> As previously described,<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> smoking measures available in UKB (ie, smoking status, age at initiation and at cessation, and number of cigarettes smoked per day) were self-reported and collected at initial assessment; smoking measures were then combined into a lifetime smoking index. GWAS summary statistics for this study<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> were publicly accessible via GWAS Catalog under study accession identifier GCST009096. After clumping, a total of 121 genetic instruments for lifetime smoking were used for the MR analyses (Supplementary Table V, available via Mendeley at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.17632/cnkvc82bgr.1" id="PC_linkfdjdBfpVQ8">https://doi.org/10.17632/cnkvc82bgr.1</ext-link>).</p></sec><sec id="sec2.4"><title>Genome-wide genetic correlation analyses</title><p id="p0070">We assessed genetic correlations (<italic toggle="yes">r</italic><sub><italic toggle="yes">g</italic></sub>) between the 3 cigarette smoking traits using cross-trait linkage disequilibrium score regression<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> and using the above-mentioned GWAS summary statistics for smoking initiation and cigarettes per day<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> and for lifetime smoking.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref></p></sec><sec id="sec2.5"><title>Two-sample MR analyses</title><p id="p0075">All analyses were conducted in the R software (V.4.0.1) using the &#8220;TwoSampleMR&#8221; package.<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> This package makes causal inference about an exposure on an outcome using GWAS summary statistics, generates LD pruning of exposure SNPs, and harmonizes exposure and outcome data sets. We used the inverse-variance weighted (IVW) method as our primary source of MR estimates. This IVW method essentially translates to a weighted regression of SNP outcome effects on SNP-exposure effects where the intercept is constrained to zero. Moreover, we reported the estimations from MR weighted median, weighted mode, and MR-Egger. Furthermore, leave-one-SNP-out analyses were conducted (Supplementary Tables VI-VIII, available via Mendeley at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.17632/cnkvc82bgr.1" id="PC_linkiYk6INWaLF">https://doi.org/10.17632/cnkvc82bgr.1</ext-link>).</p></sec><sec id="sec2.6"><title>Sensitivity analyses</title><p id="p0080">The potential effect of pleiotropy was evaluated by the regression intercept from the MR-Egger method<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> and Cochran Q tests were used to evaluate the presence of global heterogeneity amongst the effects of the genetic instruments<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> (Supplementary Table IX, available via Mendeley at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.17632/cnkvc82bgr.1" id="PC_linkMMku7nrcU7">https://doi.org/10.17632/cnkvc82bgr.1</ext-link>). The MR-PRESSO<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref><sup>,</sup><xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> method was also used to provide an MR estimate which is robust against the presence of heterogeneity among SNP effects and to re-assess the MR estimate after excluding outlier SNPs.</p></sec></sec><sec id="sec3"><title>Results</title><sec id="sec3.1"><title>Lifetime smoking exposure shares genetic determinants with smoking initiation and cigarettes per day</title><p id="p0085">To quantify genetic overlap between the 3 exposures, genome-wide genetic correlation analyses were performed using cross-trait linkage disequilibrium score regression.<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> Lifetime smoking exposure was genetically associated with smoking initiation (<italic toggle="yes">r</italic><sub><italic toggle="yes">g</italic></sub>, 0.87; SE, 0.01; <italic toggle="yes">P</italic>&#160;=&#160;1.0&#160;&#215;&#160;10<sup>-300</sup>) and&#160;cigarettes per day (<italic toggle="yes">r</italic><sub><italic toggle="yes">g</italic></sub>, 0.52; SE, 0.02; <italic toggle="yes">P</italic>&#160;=&#160;1.28&#160;&#215;&#160;10<sup>-165</sup>). Consistently, we also found evidence of genetic association between cigarettes per day and cigarette smoking initiation (<italic toggle="yes">r</italic><sub><italic toggle="yes">g</italic></sub>, 0.26; SE, 0.03; <italic toggle="yes">P</italic>&#160;=&#160;5.57&#160;&#215;&#160;10<sup>-19</sup>), as previously reported in the GSCAN study.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref></p></sec><sec id="sec3.2"><title>Mendelian randomization analyses</title><p id="p0090">We conducted two-sample MR analyses to investigate whether cigarette smoking traits causally influenced cSCC risk. No significant association was found between smoking initiation or the number of cigarettes smoked per day and cSCC risk (<xref rid="tbl1" ref-type="table">Table I</xref> and Supplementary Figs 1 and 2, available via Mendeley at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.17632/cnkvc82bgr.1" id="PC_link2BzrFFJxfO">https://doi.org/10.17632/cnkvc82bgr.1</ext-link>). In contrast, we found evidence for a causal effect of lifetime smoking exposure on cSCC risk, as an increase in lifetime smoking exposure was associated with an increased risk of cSCC (IVW model: odds ratio [OR] per one-unit increase&#160;=&#160;1.47; 95% CI, 1.09-1.98; <italic toggle="yes">P</italic>&#160;=&#160;.012) (<xref rid="tbl1" ref-type="table">Table I</xref> and <xref rid="fig1" ref-type="fig">Fig 1</xref>).<table-wrap position="float" id="tbl1" orientation="portrait"><label>Table I</label><caption><p>MR results of the associations of genetically predicted cigarette smoking traits with cSCC risk</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Exposure (source)</th><th colspan="1" rowspan="1">Outcome</th><th colspan="1" rowspan="1">N genetic instruments</th><th colspan="1" rowspan="1">MR method</th><th colspan="1" rowspan="1">OR (95%CI)</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic>-value</th><th colspan="1" rowspan="1">Detected outlier SNP via MR-PRESSO</th></tr></thead><tbody><tr><td rowspan="2" colspan="1">Cigarette smoking initiation (GSCAN)</td><td rowspan="2" colspan="1">cSCC (GERA)</td><td align="char" colspan="1" rowspan="1">236</td><td colspan="1" rowspan="1">IVW</td><td align="char" colspan="1" rowspan="1">0.99 (0.79-1.25)</td><td align="char" colspan="1" rowspan="1">.94</td><td colspan="1" rowspan="1"/></tr><tr><td align="char" colspan="1" rowspan="1">235</td><td colspan="1" rowspan="1">MR-PRESSO model</td><td align="char" colspan="1" rowspan="1">0.94 (0.86-1.26)</td><td align="char" colspan="1" rowspan="1">.69</td><td colspan="1" rowspan="1">rs7195043</td></tr><tr><td rowspan="2" colspan="1">Cigarettes per day (GSCAN)</td><td rowspan="2" colspan="1">cSCC (GERA)</td><td align="char" colspan="1" rowspan="1">45</td><td colspan="1" rowspan="1">IVW</td><td align="char" colspan="1" rowspan="1">0.91 (0.68-1.21)</td><td align="char" colspan="1" rowspan="1">.50</td><td colspan="1" rowspan="1"/></tr><tr><td align="char" colspan="1" rowspan="1">44</td><td colspan="1" rowspan="1">MR-PRESSO model</td><td align="char" colspan="1" rowspan="1">0.96 (0.75-1.23)</td><td align="char" colspan="1" rowspan="1">.76</td><td colspan="1" rowspan="1">rs2016968</td></tr><tr><td rowspan="2" colspan="1">Lifetime smoking (UKB)</td><td rowspan="2" colspan="1">cSCC (GERA)</td><td align="char" colspan="1" rowspan="1">121</td><td colspan="1" rowspan="1">IVW</td><td align="char" colspan="1" rowspan="1">1.47 (1.09-1.98)</td><td align="char" colspan="1" rowspan="1"><bold>.012</bold></td><td colspan="1" rowspan="1"/></tr><tr><td align="char" colspan="1" rowspan="1">121</td><td colspan="1" rowspan="1">MR-PRESSO model</td><td align="char" colspan="1" rowspan="1">1.46 (1.09-1.97)</td><td align="char" colspan="1" rowspan="1"><bold>.013</bold></td><td colspan="1" rowspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn id="tspara0015"><p><italic toggle="yes">P</italic>-values reported in this table represent the statistical significance of the association between the exposure of interest (genetically determined smoking trait) and the outcome (cSCC risk). A threshold of <italic toggle="yes">P</italic>&#160;&lt;&#160;.05 was used to determine significance and bold&#160;<italic toggle="yes">P</italic>-values are considered significant.</p></fn><fn id="tspara0020"><p><italic toggle="yes">CI</italic>, Confidence interval; <italic toggle="yes">cSCC</italic>, cutaneous squamous cell carcinoma; <italic toggle="yes">GERA</italic>, Genetic Epidemiology Research on Adult Health and Aging; <italic toggle="yes">GSCAN</italic>, GWAS and Sequencing Consortium of Alcohol and Nicotine use; <italic toggle="yes">IVW</italic>, inverse-variance weighted model; <italic toggle="yes">MR</italic>, Mendelian randomization; <italic toggle="yes">OR</italic>, odds ratio; <italic toggle="yes">SNP</italic>, single-nucleotide polymorphism; <italic toggle="yes">UKB</italic>, UK Biobank.</p></fn></table-wrap-foot></table-wrap><fig id="fig1" position="float" orientation="portrait"><label>Fig 1</label><caption><p>Association of lifetime smoking variants with the risk of cSCC. The x-axis shows 121 genetic instruments for lifetime smoking and their effect size estimates (ORs) with lifetime smoking. The y-axis shows the association of the same variants with cSCC risk. The Mendelian randomization (<italic toggle="yes">MR</italic>) inverse-weighted (<italic toggle="yes">IVW</italic>) regression line is plotted, along with MR Egger, simple mode, and weighted median model. <italic toggle="yes">cSCC</italic>, Cutaneous squamous cell carcinoma; <italic toggle="yes">OR</italic>, odds ratio; <italic toggle="yes">SNP</italic>, single-nucleotide polymorphism.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p></sec><sec id="sec3.3"><title>Sensitivity analyses</title><p id="p0095">No evidence of directional or horizontal pleiotropy was observed for all the analyses, as indicated by MR-Egger intercept <italic toggle="yes">P</italic>-values greater than 0.05. Furthermore, using the Cochran Q statistic, no significant heterogeneity was observed among the effects of the genetic instruments for lifetime smoking exposure (Q&#160;=&#160;117.58, <italic toggle="yes">P</italic>&#160;=&#160;.55) (Supplementary Table XI, available via Mendeley at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.17632/cnkvc82bgr.1" id="PC_link75kfBtezGv">https://doi.org/10.17632/cnkvc82bgr.1</ext-link>). Finally, the MR-PRESSO test detected no outliers for lifetime smoking exposure (<xref rid="tbl1" ref-type="table">Table I</xref>).</p></sec></sec><sec id="sec4"><title>Discussion</title><p id="p0100">Using MR on GWAS summary statistics from the Kaiser Permanente GERA cohort (7701 cSCC cases and 60,167 controls, all non-Hispanic whites), we found modest evidence that genetically determined lifetime smoking was significantly associated with cSCC, though there was no evidence of an association between genetically determined smoking initiation and amount smoked (cigarettes per day).</p><p id="p0105">Our results support the findings of previous observational studies, which reported heterogeneous relationships of smoking traits with cSCC risk, depending on the trait tested and study population.<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref><sup>,</sup><xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> Although our study used GWAS summary statistics from the largest study of smoking traits published to date (GSCAN consortium),<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> which provided powerful genetic instruments for MR analyses, we did not observe evidence of causal relationship between smoking initiation or cigarettes per day and cSCC risk. In contrast, we found that genetically determined lifetime smoking was significantly associated with an increased risk of cSCC.</p><p id="p0110">Our MR analyses were performed using valid IVs for causal inference under the 3 assumptions required for MR studies.<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref><sup>,</sup><xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> The first assumption (ie, the IV should be truly associated with the exposure) was satisfied by the use of genetic variants previously reported as genome-wide significant in large studies,<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> making those strong genetic instruments for cigarette smoking traits. The second assumption (ie, the IV should not be influenced by any confounders of the exposure-outcome association) was partially satisfied by the fact that we found similar results using the MR-PRESSO method, which is a robust method for sensitivity analysis. The third assumption (ie, the IV should only be related to the outcome of interest through the exposure under study) was satisfied because no evidence of horizontal pleiotropy was detected. Altogether, our findings were unlikely to be affected by the violation of MR assumptions. Nevertheless, recent MR studies<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref><sup>,</sup><xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> suggested that existing methods for detecting and accounting for horizontal pleiotropy are ineffective under some plausible conditions. Furthermore, genetic instruments for complex behavioral factors such as smoking traits seem to demonstrate horizontal pleiotropy.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> Future MR investigations using genetic instruments for smoking traits may include negative control outcomes (ie, an outcome for which it is believed that the exposure cannot be causal) as an approach to avoid the violation of the IV assumptions (such as through pleiotropy).<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref><sup>,</sup><xref rid="bib34" ref-type="bibr"><sup>34</sup></xref></p><p id="p0115">There are potential limitations to the current study. First, analyzing data sets (for the exposures and outcome) of individuals with the same ancestry (i.e.&#160;European ancestry) helped reduce linkage disequilibrium, but our conclusions may have limited applications to individuals of non-European ancestry. Future studies can explore if there is a significant association between smoking traits and cSCC risk in populations of different ancestries. A previous single-center retrospective chart review study suggested a strong association between smoking and age of cSCC diagnosis in non-European populations,<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> and MR analysis can help further elucidate this possible association. Second, deriving exposures (ie smoking initiation and cigarettes per day) from GWAS summary data combining many heterogeneous cohorts (versus from a unique homogeneous cohort (i.e. UKB for lifetime smoking)) could be considered as a study limitation. Furthermore, cohort characteristics from which exposures were derived would have led to potential selection bias; for instance, lifetime smoking was derived from UKB, with participants being less likely to be a smoker and overall healthier than the general UK population.<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> Third, in the current study, we did not consider epigenetic changes that could modulate gene expression and distort the effect that MR finds between a genetic variant and an outcome. Thus, future MR studies ideally would incorporate information about epigenetic changes on the genetic variants in the data analysis.<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref><sup>,</sup><xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> Fourth, we acknowledge the limitations of MR to help determine causal associations given the assumptions that must be made before applying this technique. By assuming that humans are all randomly assigned genetic variants from their parents, we have also assumed that these genes are fully penetrant and not significantly impacted by environmental factors such as UV exposure, diet, or other factors that may influence cSCC risk.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="bib39" ref-type="bibr"><sup>39</sup></xref> In essence, disease development such as cSCC consists of multifactorial, dynamic, nonlinear biological processes, and MR is limited in accounting for that complexity. Future studies can expand on this research by analyzing the interplay between genetic predispositions for smoking, UV exposure, diet, and other behaviors on cSCC risk.</p><p id="p0120">Although no causal associations of smoking initiation and smoking amount with SCC risk were detected, we observed support for a causal association of lifetime smoking with SCC risk. Lifetime smoking exposure is based on an index that incorporates total duration of smoking, time since smoking cessation, average number of cigarettes smoked per day, and selected covariable interactions to form an aggregate measurement.<xref rid="bib40" ref-type="bibr"><sup>40</sup></xref> For this reason, we feel that lifetime smoking might be a more comprehensive exposure for smoking behavior, compared to smoking initiation and amount smoked per day. Previous MR studies have reported causal associations between lifetime smoking exposure and other cancers, including breast cancer and colorectal cancer, but a lack of association with other cigarette smoking traits.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref><sup>,</sup><xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> Thus, future MR studies that aim to investigate the causal relationship between cigarette smoking and outcomes should test for different smoking traits, including lifetime smoking index, as those represent different stages of cigarette use.</p><p id="p0125">In this study analyzing GWAS summary statistics of different cohorts through two-sample MR, we found support for a causal relationship between long-term smoking exposure and cSCC risk. These results support more targeted screening strategies of populations based on factors such as carcinogen exposure and genetic and clinical information. Given that lifetime smoking exposure is an aggregate measurement incorporating total duration of smoking, time since smoking cessation, average number of cigarettes smoked per day, and selected covariable interactions, our results also support an overall reduction of smoking exposure. This conclusion may have broader implications in highlighting the importance of smoking cessation initiatives in decreasing smoking exposure. Causal relationships between smoking traits and a wide range of cancers, including cancers of the lung, head and neck, esophagus, pancreas, bladder, kidney, cervix, and ovaries, and myeloid leukemia, have been reported,<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> and our results can potentially provide additional evidence for skin cancer. In conclusion, this study shows evidence for a causal relationship between long-term smoking exposure and cSCC risk, underscoring the importance of smoking prevention campaigns and more targeted screening strategies.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest</title><p id="p0130">None disclosed.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name name-style="western"><surname>Urban</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mehrmal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Uppal</surname><given-names>P.</given-names></name><name name-style="western"><surname>Giesey</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Delost</surname><given-names>G.R.</given-names></name></person-group><article-title>The global burden of skin cancer: a longitudinal analysis from the Global Burden of Disease study, 1990-2017</article-title><source>JAAD Int</source><volume>2</volume><year>2021</year><fpage>98</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.jdin.2020.10.013</pub-id><pub-id pub-id-type="pmid">34409358</pub-id><pub-id pub-id-type="pmcid">PMC8362234</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name name-style="western"><surname>Fania</surname><given-names>L.</given-names></name><name name-style="western"><surname>Didona</surname><given-names>D.</given-names></name><name name-style="western"><surname>Di Pietro</surname><given-names>F.R.</given-names></name><etal/></person-group><article-title>Cutaneous squamous cell carcinoma: from pathophysiology to novel therapeutic approaches</article-title><source>Biomedicines</source><volume>9</volume><issue>2</issue><year>2021</year><fpage>171</fpage><pub-id pub-id-type="doi">10.3390/biomedicines9020171</pub-id><pub-id pub-id-type="pmid">33572373</pub-id><pub-id pub-id-type="pmcid">PMC7916193</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name name-style="western"><surname>Diseases</surname><given-names>G.B.D.</given-names></name><name name-style="western"><surname>Injuries</surname><given-names>C.</given-names></name></person-group><article-title>Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019</article-title><source>Lancet</source><volume>396</volume><issue>10258</issue><year>2020</year><fpage>1204</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30925-9</pub-id><pub-id pub-id-type="pmid">33069326</pub-id><pub-id pub-id-type="pmcid">PMC7567026</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name name-style="western"><surname>Choquet</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ashrafzadeh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Asgari</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Jorgenson</surname><given-names>E.</given-names></name></person-group><article-title>Genetic and environmental factors underlying keratinocyte carcinoma risk</article-title><source>JCI Insight</source><volume>5</volume><issue>10</issue><year>2020</year><object-id pub-id-type="publisher-id">e134783</object-id><pub-id pub-id-type="doi">10.1172/jci.insight.134783</pub-id><pub-id pub-id-type="pmcid">PMC7259534</pub-id><pub-id pub-id-type="pmid">32434987</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name name-style="western"><surname>Walser</surname><given-names>T.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yanagawa</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Smoking and lung cancer: the role of inflammation</article-title><source>Proc Am Thorac Soc</source><volume>5</volume><issue>8</issue><year>2008</year><fpage>811</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1513/pats.200809-100TH</pub-id><pub-id pub-id-type="pmid">19017734</pub-id><pub-id pub-id-type="pmcid">PMC4080902</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name name-style="western"><surname>Jethwa</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Khariwala</surname><given-names>S.S.</given-names></name></person-group><article-title>Tobacco-related carcinogenesis in head and neck cancer</article-title><source>Cancer Metastasis Rev</source><volume>36</volume><issue>3</issue><year>2017</year><fpage>411</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1007/s10555-017-9689-6</pub-id><pub-id pub-id-type="pmid">28801840</pub-id><pub-id pub-id-type="pmcid">PMC5709040</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Schoemaker</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Wright</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Ashworth</surname><given-names>A.</given-names></name><name name-style="western"><surname>Swerdlow</surname><given-names>A.J.</given-names></name></person-group><article-title>Smoking and risk of breast cancer in the generations study cohort</article-title><source>Breast Cancer Res</source><volume>19</volume><issue>1</issue><year>2017</year><fpage>118</fpage><pub-id pub-id-type="doi">10.1186/s13058-017-0908-4</pub-id><pub-id pub-id-type="pmid">29162146</pub-id><pub-id pub-id-type="pmcid">PMC5698948</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name name-style="western"><surname>Roura</surname><given-names>E.</given-names></name><name name-style="western"><surname>Castellsague</surname><given-names>X.</given-names></name><name name-style="western"><surname>Pawlita</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort</article-title><source>Int J Cancer</source><volume>135</volume><issue>2</issue><year>2014</year><fpage>453</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1002/ijc.28666</pub-id><pub-id pub-id-type="pmid">24338632</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name name-style="western"><surname>Lynch</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Vrieling</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lubin</surname><given-names>J.H.</given-names></name><etal/></person-group><article-title>Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium</article-title><source>Am J Epidemiol</source><volume>170</volume><issue>4</issue><year>2009</year><fpage>403</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1093/aje/kwp134</pub-id><pub-id pub-id-type="pmid">19561064</pub-id><pub-id pub-id-type="pmcid">PMC2733861</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name name-style="western"><surname>Dusingize</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Pandeya</surname><given-names>N.P.</given-names></name><etal/></person-group><article-title>Cigarette smoking and the risks of basal cell carcinoma and squamous cell carcinoma</article-title><source>J Invest Dermatol</source><volume>137</volume><issue>8</issue><year>2017</year><fpage>1700</fpage><lpage>1708</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2017.03.027</pub-id><pub-id pub-id-type="pmid">28414022</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name name-style="western"><surname>Pirie</surname><given-names>K.</given-names></name><name name-style="western"><surname>Beral</surname><given-names>V.</given-names></name><name name-style="western"><surname>Heath</surname><given-names>A.K.</given-names></name><etal/></person-group><article-title>Heterogeneous relationships of squamous and basal cell carcinomas of the skin with smoking: the UK Million Women Study and meta-analysis of prospective studies</article-title><source>Br J Cancer</source><volume>119</volume><issue>1</issue><year>2018</year><fpage>114</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1038/s41416-018-0105-y</pub-id><pub-id pub-id-type="pmid">29899391</pub-id><pub-id pub-id-type="pmcid">PMC6035218</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>F.</given-names></name><name name-style="western"><surname>Qureshi</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>Han</surname><given-names>J.</given-names></name></person-group><article-title>Smoking and risk of skin cancer: a prospective analysis and a meta-analysis</article-title><source>Int J Epidemiol</source><volume>41</volume><issue>6</issue><year>2012</year><fpage>1694</fpage><lpage>1705</lpage><pub-id pub-id-type="doi">10.1093/ije/dys146</pub-id><pub-id pub-id-type="pmid">23064412</pub-id><pub-id pub-id-type="pmcid">PMC3535753</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name name-style="western"><surname>Davey Smith</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hemani</surname><given-names>G.</given-names></name></person-group><article-title>Mendelian randomization: genetic anchors for causal inference in epidemiological studies</article-title><source>Hum Mol Genet</source><volume>23</volume><issue>R1</issue><year>2014</year><fpage>R89</fpage><lpage>R98</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddu328</pub-id><pub-id pub-id-type="pmid">25064373</pub-id><pub-id pub-id-type="pmcid">PMC4170722</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name name-style="western"><surname>Nitsch</surname><given-names>D.</given-names></name><name name-style="western"><surname>Molokhia</surname><given-names>M.</given-names></name><name name-style="western"><surname>Smeeth</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials</article-title><source>Am J Epidemiol</source><volume>163</volume><issue>5</issue><year>2006</year><fpage>397</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1093/aje/kwj062</pub-id><pub-id pub-id-type="pmid">16410347</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name name-style="western"><surname>Asgari</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ioannidis</surname><given-names>N.M.</given-names></name><etal/></person-group><article-title>Identification of susceptibility loci for cutaneous squamous cell carcinoma</article-title><source>J Invest Dermatol</source><volume>136</volume><issue>5</issue><year>2016</year><fpage>930</fpage><lpage>937</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2016.01.013</pub-id><pub-id pub-id-type="pmid">26829030</pub-id><pub-id pub-id-type="pmcid">PMC4842155</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name name-style="western"><surname>Kvale</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Hesselson</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>T.J.</given-names></name><etal/></person-group><article-title>Genotyping informatics and quality control for 100,000 subjects in the genetic epidemiology research on adult health and aging (GERA) cohort</article-title><comment>Research support, N.I.H., extramural research support, non-U.S. Gov't</comment><source>Genetics</source><volume>200</volume><issue>4</issue><year>2015</year><fpage>1051</fpage><lpage>1060</lpage><pub-id pub-id-type="doi">10.1534/genetics.115.178905</pub-id><pub-id pub-id-type="pmid">26092718</pub-id><pub-id pub-id-type="pmcid">PMC4574249</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name name-style="western"><surname>Banda</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kvale</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>T.J.</given-names></name><etal/></person-group><article-title>Characterizing race/ethnicity and genetic ancestry for 100,000 subjects in the genetic epidemiology research on adult health and aging (GERA) cohort</article-title><comment>Research support, N.I.H., extramural research support, non-U.S. Gov't</comment><source>Genetics</source><volume>200</volume><issue>4</issue><year>2015</year><fpage>1285</fpage><lpage>1295</lpage><pub-id pub-id-type="doi">10.1534/genetics.115.178616</pub-id><pub-id pub-id-type="pmid">26092716</pub-id><pub-id pub-id-type="pmcid">PMC4574246</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name name-style="western"><surname>Saunders</surname><given-names>G.R.B.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Genetic diversity fuels&#160;gene discovery for tobacco and alcohol use</article-title><source>Nature</source><volume>612</volume><issue>7941</issue><year>2022</year><fpage>720</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-05477-4</pub-id><pub-id pub-id-type="pmid">36477530</pub-id><pub-id pub-id-type="pmcid">PMC9771818</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name name-style="western"><surname>Choquet</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jorgenson</surname><given-names>E.</given-names></name></person-group><article-title>Cigarette smoking behaviors and the importance of ethnicity and genetic ancestry</article-title><source>Transl Psychiatry</source><volume>11</volume><issue>1</issue><year>2021</year><fpage>120</fpage><pub-id pub-id-type="doi">10.1038/s41398-021-01244-7</pub-id><pub-id pub-id-type="pmid">33633108</pub-id><pub-id pub-id-type="pmcid">PMC7907280</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name name-style="western"><surname>Wootton</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Richmond</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Stuijfzand</surname><given-names>B.G.</given-names></name><etal/></person-group><article-title>Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study</article-title><source>Psychol Med</source><volume>50</volume><issue>14</issue><year>2020</year><fpage>2435</fpage><lpage>2443</lpage><pub-id pub-id-type="doi">10.1017/S0033291719002678</pub-id><pub-id pub-id-type="pmid">31689377</pub-id><pub-id pub-id-type="pmcid">PMC7610182</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name name-style="western"><surname>Sudlow</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gallacher</surname><given-names>J.</given-names></name><name name-style="western"><surname>Allen</surname><given-names>N.</given-names></name><etal/></person-group><article-title>UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age</article-title><source>PLoS Med</source><volume>12</volume><issue>3</issue><year>2015</year><object-id pub-id-type="publisher-id">e1001779</object-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1001779</pub-id><pub-id pub-id-type="pmcid">PMC4380465</pub-id><pub-id pub-id-type="pmid">25826379</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name name-style="western"><surname>Bulik-Sullivan</surname><given-names>B.K.</given-names></name><name name-style="western"><surname>Loh</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Finucane</surname><given-names>H.K.</given-names></name><etal/></person-group><article-title>LD Score regression distinguishes confounding from polygenicity in genome-wide association studies</article-title><source>Nat Genet</source><volume>47</volume><issue>3</issue><year>2015</year><fpage>291</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1038/ng.3211</pub-id><pub-id pub-id-type="pmid">25642630</pub-id><pub-id pub-id-type="pmcid">PMC4495769</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name name-style="western"><surname>Hemani</surname><given-names>G.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Elsworth</surname><given-names>B.</given-names></name><etal/></person-group><article-title>The MR-Base platform supports systematic causal inference across the human phenome</article-title><source>Elife</source><volume>7</volume><year>2018</year><object-id pub-id-type="publisher-id">e34408</object-id><pub-id pub-id-type="doi">10.7554/eLife.34408</pub-id><pub-id pub-id-type="pmcid">PMC5976434</pub-id><pub-id pub-id-type="pmid">29846171</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name name-style="western"><surname>Bowden</surname><given-names>J.</given-names></name><name name-style="western"><surname>Davey Smith</surname><given-names>G.</given-names></name><name name-style="western"><surname>Burgess</surname><given-names>S.</given-names></name></person-group><article-title>Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression</article-title><source>Int J Epidemiol</source><volume>44</volume><issue>2</issue><year>2015</year><fpage>512</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1093/ije/dyv080</pub-id><pub-id pub-id-type="pmid">26050253</pub-id><pub-id pub-id-type="pmcid">PMC4469799</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name name-style="western"><surname>Burgess</surname><given-names>S.</given-names></name><name name-style="western"><surname>Davey Smith</surname><given-names>G.</given-names></name><name name-style="western"><surname>Davies</surname><given-names>N.M.</given-names></name><etal/></person-group><article-title>Guidelines for performing Mendelian randomization investigations</article-title><source>Wellcome Open Res</source><volume>4</volume><year>2019</year><fpage>186</fpage><pub-id pub-id-type="doi">10.12688/wellcomeopenres.15555.2</pub-id><pub-id pub-id-type="pmid">32760811</pub-id><pub-id pub-id-type="pmcid">PMC7384151</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name name-style="western"><surname>Verbanck</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.Y.</given-names></name><name name-style="western"><surname>Neale</surname><given-names>B.</given-names></name><name name-style="western"><surname>Do</surname><given-names>R.</given-names></name></person-group><article-title>Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases</article-title><source>Nat Genet</source><volume>50</volume><issue>5</issue><year>2018</year><fpage>693</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0099-7</pub-id><pub-id pub-id-type="pmid">29686387</pub-id><pub-id pub-id-type="pmcid">PMC6083837</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name name-style="western"><surname>De Hertog</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Wensveen</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Bastiaens</surname><given-names>M.T.</given-names></name><etal/></person-group><article-title>Relation between smoking and skin cancer</article-title><source>J Clin Oncol</source><volume>19</volume><issue>1</issue><year>2001</year><fpage>231</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1200/JCO.2001.19.1.231</pub-id><pub-id pub-id-type="pmid">11134217</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Baird</surname><given-names>D.</given-names></name><name name-style="western"><surname>Borges</surname><given-names>M.C.</given-names></name><etal/></person-group><article-title>Recent developments in mendelian randomization studies</article-title><source>Curr Epidemiol Rep</source><volume>4</volume><issue>4</issue><year>2017</year><fpage>330</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1007/s40471-017-0128-6</pub-id><pub-id pub-id-type="pmid">29226067</pub-id><pub-id pub-id-type="pmcid">PMC5711966</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name name-style="western"><surname>Davies</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Davey Smith</surname><given-names>G.</given-names></name></person-group><article-title>Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians</article-title><source>Bmj</source><volume>362</volume><year>2018</year><object-id pub-id-type="publisher-id">k601</object-id><pub-id pub-id-type="doi">10.1136/bmj.k601</pub-id><pub-id pub-id-type="pmcid">PMC6041728</pub-id><pub-id pub-id-type="pmid">30002074</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name name-style="western"><surname>Qi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Chatterjee</surname><given-names>N.</given-names></name></person-group><article-title>A comprehensive evaluation of methods for Mendelian randomization using realistic simulations and an analysis of 38 biomarkers for risk of type 2 diabetes</article-title><source>Int J Epidemiol</source><volume>50</volume><issue>4</issue><year>2021</year><fpage>1335</fpage><lpage>1349</lpage><pub-id pub-id-type="doi">10.1093/ije/dyaa262</pub-id><pub-id pub-id-type="pmid">33393617</pub-id><pub-id pub-id-type="pmcid">PMC8562333</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Knowles</surname><given-names>D.A.</given-names></name></person-group><article-title>Welch-weighted Egger regression reduces false positives due to correlated pleiotropy in Mendelian randomization</article-title><source>Am J Hum Genet</source><volume>108</volume><issue>12</issue><year>2021</year><fpage>2319</fpage><lpage>2335</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2021.10.006</pub-id><pub-id pub-id-type="pmid">34861175</pub-id><pub-id pub-id-type="pmcid">PMC8715134</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name name-style="western"><surname>Reed</surname><given-names>Z.E.</given-names></name><name name-style="western"><surname>Wootton</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Khouja</surname><given-names>J.N.</given-names></name><etal/></person-group><article-title>Exploring pleiotropy in Mendelian randomisation analyses: what are genetic variants associated with &#8220;cigarette smoking initiation&#8221; really capturing?</article-title><source>medRxiv</source><year>2023</year><object-id pub-id-type="publisher-id">23293638</object-id><pub-id pub-id-type="doi">10.1101/2023.08.04.23293638</pub-id><pub-id pub-id-type="pmcid">PMC7616876</pub-id><pub-id pub-id-type="pmid">39099143</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name name-style="western"><surname>Burgess</surname><given-names>S.</given-names></name><name name-style="western"><surname>Davey Smith</surname><given-names>G.</given-names></name><name name-style="western"><surname>Davies</surname><given-names>N.M.</given-names></name><etal/></person-group><article-title>Guidelines for performing Mendelian randomization investigations: update for summer 2023</article-title><source>Wellcome Open Res</source><volume>4</volume><year>2019</year><fpage>186</fpage><pub-id pub-id-type="doi">10.12688/wellcomeopenres.15555.3</pub-id><pub-id pub-id-type="pmid">32760811</pub-id><pub-id pub-id-type="pmcid">PMC7384151</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name name-style="western"><surname>Sanderson</surname><given-names>E.</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>T.G.</given-names></name><name name-style="western"><surname>Hemani</surname><given-names>G.</given-names></name><name name-style="western"><surname>Davey Smith</surname><given-names>G.</given-names></name></person-group><article-title>The use of negative control outcomes in Mendelian randomization to detect potential population stratification</article-title><source>Int J Epidemiol</source><volume>50</volume><issue>4</issue><year>2021</year><fpage>1350</fpage><lpage>1361</lpage><pub-id pub-id-type="doi">10.1093/ije/dyaa288</pub-id><pub-id pub-id-type="pmid">33570130</pub-id><pub-id pub-id-type="pmcid">PMC8407870</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name name-style="western"><surname>Nadhan</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Buchanan</surname><given-names>E.M.</given-names></name><etal/></person-group><article-title>Risk factors for keratinocyte carcinoma skin cancer in nonwhite individuals: a retrospective analysis</article-title><source>J Am Acad Dermatol</source><volume>81</volume><issue>2</issue><year>2019</year><fpage>373</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2019.01.038</pub-id><pub-id pub-id-type="pmid">30703457</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name name-style="western"><surname>Munafo</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Tilling</surname><given-names>K.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Evans</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Davey Smith</surname><given-names>G.</given-names></name></person-group><article-title>Collider scope: when selection bias can substantially influence observed associations</article-title><source>Int J Epidemiol</source><volume>47</volume><issue>1</issue><year>2018</year><fpage>226</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1093/ije/dyx206</pub-id><pub-id pub-id-type="pmid">29040562</pub-id><pub-id pub-id-type="pmcid">PMC5837306</pub-id></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name name-style="western"><surname>Ogbuanu</surname><given-names>I.U.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Karmaus</surname><given-names>W.</given-names></name></person-group><article-title>Can we apply the Mendelian randomization methodology without considering epigenetic effects?</article-title><source>Emerg Themes Epidemiol</source><volume>6</volume><year>2009</year><fpage>3</fpage><pub-id pub-id-type="doi">10.1186/1742-7622-6-3</pub-id><pub-id pub-id-type="pmid">19432981</pub-id><pub-id pub-id-type="pmcid">PMC2698894</pub-id></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name name-style="western"><surname>Relton</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Davey Smith</surname><given-names>G.</given-names></name></person-group><article-title>Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease</article-title><source>Int J Epidemiol</source><volume>41</volume><issue>1</issue><year>2012</year><fpage>161</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1093/ije/dyr233</pub-id><pub-id pub-id-type="pmid">22422451</pub-id><pub-id pub-id-type="pmcid">PMC3304531</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name name-style="western"><surname>Lucock</surname><given-names>M.D.</given-names></name></person-group><article-title>The evolution of human skin pigmentation: a changing medley of vitamins, genetic variability, and UV radiation during human expansion</article-title><source>Am J Biol Anthropol</source><volume>180</volume><issue>2</issue><year>2023</year><fpage>252</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1002/ajpa.24564</pub-id><pub-id pub-id-type="pmid">36790744</pub-id><pub-id pub-id-type="pmcid">PMC10083917</pub-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name name-style="western"><surname>Leffondre</surname><given-names>K.</given-names></name><name name-style="western"><surname>Abrahamowicz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Siemiatycki</surname><given-names>J.</given-names></name></person-group><article-title>Modelling smoking history using a comprehensive smoking index: application to lung cancer</article-title><source>Stat Med</source><volume>25</volume><issue>24</issue><year>2006</year><fpage>4132</fpage><lpage>4146</lpage><pub-id pub-id-type="doi">10.1002/sim.2680</pub-id><pub-id pub-id-type="pmid">16998807</pub-id></element-citation></ref></ref-list><ack id="ack0010"><p id="p0135">We are grateful to the Kaiser Permanente Northern California members who have generously agreed to participate in the Kaiser Permanente Research Program on Genes, Environment, and Health. Support for participant enrollment, survey completion, and biospecimen collection for the RPGEH was provided by the <funding-source id="gs8"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000867</institution-id><institution>Robert Wood Johnson Foundation</institution></institution-wrap></funding-source>, the <funding-source id="gs9"><institution-wrap><institution-id institution-id-type="doi">10.13039/100001370</institution-id><institution>Wayne and Gladys Valley Foundation</institution></institution-wrap></funding-source>, the <funding-source id="gs10"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000863</institution-id><institution>Ellison Medical Foundation</institution></institution-wrap></funding-source>, and <funding-source id="gs14">Kaiser Permanente Community Benefit Programs</funding-source>. Genotyping of the GERA cohort was funded by a grant from the <funding-source id="gs12"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source>, <funding-source id="gs13"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000025</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source>, and <funding-source id="gs16">National Institute of Health Common Fund</funding-source> (RC2 AG036607). This study was funded by the National Cancer Institute&#160;(NCI) grant&#160;R01 CA241623.</p><p id="p0140">Access to data and data analysis: C. J. and H. C. had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</p></ack><fn-group><fn id="d35e161"><p id="ntpara0010">Drs Lee and George contributed equally to this article.</p></fn><fn id="d35e164"><p id="ntpara0015">Funding sources: H.C. and M.M.A. are supported by the <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source> (NCI) grant R01CA241623. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p></fn><fn id="d35e173"><p id="ntpara0020">IRB approval status: The Institutional Review Board of the Kaiser Foundation Research Institute approved all study procedures, and written informed consent was obtained from all participants.</p></fn></fn-group></back></article></pmc-articleset>